Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

LifeMD Inc

Healthcare US LFMD

3.91USD
0.79(25.32%)

Last update at 2026-03-10T20:25:00Z

Day Range

3.464.06
LowHigh

52 Week Range

1.9512.88
LowHigh

Fundamentals

  • Previous Close 3.12
  • Market Cap331.55M
  • Volume6086953
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-16.60162M
  • Revenue TTM163.56M
  • Revenue Per Share TTM4.57
  • Gross Profit TTM 100.37M
  • Diluted EPS TTM-0.74

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -44.66033M -61.31636M -60.40185M -3.65076M -1.48479M
Minority interest 0.51M 0.43M -2.17569M -0.14106M -0.07796M
Net income -45.02103M -61.32406M -60.52435M -3.52826M -1.24083M
Selling general administrative 46.96M 39.57M 42.21M 2.40M 3.33M
Selling and marketing expenses 78.37M 82.54M 41.67M 8.17M 5.08M
Gross profit 100.37M 74.88M 28.39M 9.20M 6.36M
Reconciled depreciation 3.77M 0.87M 0.40M 0.34M 0.20M
Ebit -39.68619M -54.30108M -58.21722M -2.88961M -1.13040M
Ebitda -32.21775M -49.43677M -57.81945M -2.55400M -0.93463M
Depreciation and amortization 7.47M 4.86M 0.40M 0.34M 0.20M
Non operating income net other - -3.99556M -0.91486M - -
Operating income -39.68619M -54.30108M -57.81945M -2.88961M -2.05614M
Other operating expenses 158.72M 147.18M 95.11M 15.36M 10.38M
Interest expense 1.28M -3.01972M 1.67M -0.76115M 0.35M
Tax provision 0.36M 0.00770M 0.12M -0.12250M -0.12470M
Interest income - - - - -
Net interest income -1.27595M -3.01972M -1.66754M -0.76115M -0.35439M
Extraordinary items - - - - -
Non recurring 3.76M - - - -
Other items - - - - -
Income tax expense 0.36M 0.00770M 0.12M -0.12250M -0.12470M
Total revenue 119.03M 92.88M 37.29M 12.47M 8.32M
Total operating expenses 140.05M 129.18M 86.21M 12.09M 8.41M
Cost of revenue 18.67M 18.00M 8.91M 3.27M 1.97M
Total other income expense net -4.97414M -7.01527M -2.58240M -0.76115M 0.57M
Discontinued operations - - - - 0.93M
Net income from continuing ops -45.02103M -61.32406M -60.52435M -3.52826M -1.36009M
Net income applicable to common shares -48.64191M -61.76918M -63.36296M -3.13720M -1.24083M
Preferred stock and other adjustments 3.11M 0.87M 4.72M - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 58.48M 25.67M 49.92M 13.05M 3.45M
Intangible assets 14.81M 12.67M 3.02M 0.72M 0.68M
Earning assets - - - - -
Other current assets 1.42M 0.69M 0.79M 0.15M 0.44M
Total liab 52.91M 32.97M 24.10M 13.88M 4.58M
Total stockholder equity 3.51M -6.82995M 26.85M 1.35M -0.98818M
Deferred long term liab - - - - -
Other current liab 13.94M 12.17M 11.60M 11.79M 3.05M
Common stock 0.38M 0.32M 0.31M 0.23M 0.53M
Capital stock 0.38M 4.88M 4.42M 3.89M 0.53M
Retained earnings -214.26524M -190.56299M -141.92109M -80.15190M -16.59492M
Other liab - 1.02M 0.10M 0.10M 0.57M
Good will - - - - -
Other assets 0.00000M - - - -
Cash 33.15M 3.96M 41.33M 9.18M 1.11M
Cash and equivalents - - - - -
Total current liabilities 34.78M 31.37M 22.83M 13.49M 3.98M
Current deferred revenue 8.83M 5.55M 1.50M 0.92M 0.11M
Net debt -14.21437M 0.17M -39.47861M -8.11462M -0.26191M
Short term debt 0.93M 3.55M 0.67M 0.78M 0.81M
Short long term debt 0.33M 2.80M 0.06M 0.78M 0.81M
Short long term debt total 18.93M 4.13M 1.85M 1.06M 0.84M
Other stockholder equity 217.39M 178.85M 164.35M 77.62M 15.07M
Property plant equipment - 0.48M 1.99M 0.27M 0.02M
Total current assets 42.60M 11.31M 44.92M 12.06M 2.75M
Long term investments - - - - -
Net tangible assets - -19.50214M 19.72M -3.01772M -1.66364M
Short term investments - - - - -
Net receivables 5.28M 2.83M 0.98M 0.65M 0.10M
Long term debt 17.93M - - - -
Inventory 2.76M 3.70M 1.62M 1.26M 0.95M
Accounts payable 11.08M 10.11M 9.06M 11.74M 3.05M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - -0.47555M -1.03174M -2.17569M -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.00014M - - - -
Additional paid in capital - - - - -
Common stock total equity - 0.32M 0.31M 0.23M 0.53M
Preferred stock total equity - 0.00014M 0.00014M - -
Retained earnings total equity - -190.56299M -141.92109M -80.15190M -
Treasury stock - -0.16370M -0.16370M -0.16370M -
Accumulated amortization - - - - -
Non currrent assets other -0.00000M 9.32M 3.23M 0.38M -
Deferred long term asset charges - - - - -
Non current assets total 15.88M 14.35M 5.00M 0.99M 0.70M
Capital lease obligations 0.68M 1.33M 1.79M 0.29M 0.03M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -13.90573M -3.40229M -0.79814M -0.10000M 0.14M
Change to liabilities 3.10M 9.55M 10.30M 2.22M 0.34M
Total cashflows from investing activities -13.90573M -3.40229M -0.79814M -0.10000M 0.14M
Net borrowings 2.74M -0.53082M 0.09M 0.80M 0.64M
Total cash from financing activities -0.52820M 68.64M 21.00M 0.78M 0.80M
Change to operating activities - -0.02510M -0.57117M -0.28966M -0.28681M
Net income -45.02103M -61.32406M -60.52435M -3.52826M -1.36009M
Change in cash -37.36908M 32.15M 8.07M 0.93M 0.04M
Begin period cash flow 41.33M 9.18M 1.11M 0.18M 0.14M
End period cash flow 3.96M 41.33M 9.18M 1.11M 0.18M
Total cash from operating activities -22.93515M -33.08549M -12.13161M 0.25M -0.90552M
Issuance of capital stock 0.00000M 69.33M 20.13M 0.35M 0.00000M
Depreciation 3.77M 0.87M 0.40M 0.34M 0.20M
Other cashflows from investing activities -13.53910M -3.15492M -0.79814M - 0.39M
Dividends paid -3.10625M -0.87148M -1.28966M 0.87M 0.87M
Change to inventory -2.18301M -0.40982M -0.31420M 0.07M -0.34136M
Change to account receivables -2.19289M 0.02M -0.55097M 0.00161M 0.03M
Sale purchase of stock -0.01510M 72.46M 1.29M - 0.00000M
Other cashflows from financing activities 2.75M -0.44400M 6.26M 0.72M 1.04M
Change to netincome 17.95M 15.72M 35.93M 0.43M 0.08M
Capital expenditures 12.89M 3.40M 0.40M 0.25M 0.10M
Change receivables -2.19289M 0.02M -0.55097M - -
Cash flows other operating 4.05M 0.51M -0.01341M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -37.36908M 32.15M 8.07M - -
Change in working capital -1.54904M 9.13M 8.80M 2.07M -0.25597M
Stock based compensation 13.73M 12.07M 18.66M 0.73M 0.27M
Other non cash items 5.78M 2.11M 19.63M 0.58M 0.24M
Free cash flow -35.82849M -36.48778M -12.52975M 0.25M -1.00552M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LFMD
LifeMD Inc		 0.79 25.32% 3.91 - 32.15 2.48 107.72 2.38 -46.0615
GEHC
GE HealthCare Technologies Inc.		 -2.9 3.83% 72.73 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -5.88 3.01% 189.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 11.42 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.07 1.34% 5.17 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD Inc

236 Fifth Avenue, New York, NY, United States, 10001

Key Executives

Name Title Year Born
Mr. Justin Schreiber Chairman & CEO 1983
Mr. Alexander Mironov Pres 1980
Mr. Marc Benathen Chief Financial Officer 1981
Mr. Brad Michael Roberts Chief Operating Officer 1981
Ms. Maria E. Stan CPA Controller & Principal Accounting Officer 1975
Mr. Dennis Wijnker Chief Technology Officer 1976
Mr. Eric H. Yecies Chief Compliance Officer, Gen. Counsel & Sec. 1978
Mr. Stefan Galluppi Chief Innovation & Marketing Officer and Director 1987
Ms. Tameca Brown VP of HR NA
Mr. Nicholas P. Alvarez Chief Acquisition Officer & Head of Customer Acquisition 1982

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.